Pharmacology, Toxicology and Pharmaceutical Science
Andrographolide
93%
Phytochemical
77%
Digestant
66%
Andrographis
66%
Prevalence
66%
Colorectal Carcinoma
66%
Fluorouracil
66%
Diabetes Mellitus
66%
Liver Cell Carcinoma
66%
Streptozotocin
66%
Cyclophosphamide
66%
Sesbania
66%
Dermatitis
66%
Carcinoembryonic Antigen
44%
Caspase 9
44%
Caspase 3
44%
Protein P53
44%
Diterpenoid
40%
Condyloma acuminatum
33%
Tuberculin
33%
Visual Impairment
33%
Cetuximab
26%
Pandemic
26%
Diseases
24%
Messenger RNA
22%
Treatment Group
22%
Anticarcinogen
22%
Gelatinase B
22%
Cytochrome P450
22%
Bilirubin
22%
Pharmacodynamics
22%
Phytochemical Screening
22%
Enzyme-Linked Immunosorbent Assay
22%
Mycobacterium Indicus Pranii
16%
Mump
16%
Measles
16%
Human Papillomavirus
16%
Scar Formation
16%
Rubella
16%
Hydroxychloroquine
13%
Panitumumab
13%
Cancer Mortality
13%
Paraprotein
13%
Cross-Sectional Study
13%
Hydration
13%
Malignant Neoplasm
11%
Overall Survival
11%
Network Pharmacology
11%
Multidrug Resistance
11%
Glaucoma
11%
Medicine and Dentistry
Prevalence
100%
Cross Sectional Study
72%
Informed Consent
66%
Colorectal Carcinoma
66%
Sunscreen
66%
Heart Disease
66%
Epidermal Growth Factor Receptor
66%
Nevus
66%
Fanconi Anemia
66%
Adverse Event
53%
Handwashing
44%
Low Level Laser Therapy
40%
COVID-19
33%
Internal Medicine
33%
Tuberculin
33%
Genital Wart
33%
Dermatitis
33%
Visual Impairment
33%
Side Effect
26%
Sunburn
24%
Biopsy Technique
22%
Cosmetics
22%
Surgical Technique
22%
Gelatinase B
22%
Table Salt
22%
Creatinine
19%
Adverse Effect
18%
Diseases
16%
Measles
16%
Mump
16%
Mycobacterium Bovis BCG
16%
Cryotherapy
16%
Rubella
16%
Malignant Transformation
16%
Trichophyton
16%
Mycobacterium Indicus Pranii
16%
Scar Formation
16%
Topical Treatment
16%
Refractive Error
16%
Clinician
13%
Dermatology
13%
Clinical Study
13%
Patient Rights
13%
Cetuximab
13%
Paraprotein
13%
Cell Surface
13%
Cancer Mortality
13%
Neoplasm
13%
Panitumumab
13%
Immunosuppressive Treatment
13%
Biochemistry, Genetics and Molecular Biology
Streptozotocin
66%
Prevalence
66%
Platelet Derived Growth Factor Receptor Alpha
66%
Enzyme
66%
Hub Genes
50%
Gelatinase B
33%
MMP9
33%
Cross Sectional Study
33%
Body Weight
28%
Enzyme Activity
28%
Gene Expression
16%
Downregulation
16%
Overall Survival
16%
Protein-Protein Interaction Networks
16%
Cell Migration
16%
Phytochemical
16%
Upregulation
16%
Gene Ontology
16%
Multidrug Resistance
16%
Binding Energy
16%
Docking (Molecular)
16%
Programmed Cell Death
16%
Cell Growth
16%
Cell Proliferation
16%
Bioinformatics Software
16%
Glibenclamide
9%
Secretion (Process)
9%
Glycated Hemoglobin
9%
Hyperglycemia
9%
Carbohydrate Metabolism
9%
Gluconeogenesis
9%